LACK OF PHARMACOKINETIC INTERACTION BETWEEN VINPOCETINE AND OXAZEPAM

被引:2
|
作者
STORM, G
OOSTERHUIS, B
SOLLIE, FAE
VISSCHER, HW
SOMMER, W
BEITINGER, H
JONKMAN, JHG
机构
[1] PHARMA BIORES INT BV,9400 AE ZUIDLAREN,NETHERLANDS
[2] THIEMANN ARZNEIMITTEL GMBH,WALTROP,GERMANY
关键词
OXAZEPAM; VINPOCETINE; INTERACTION; PLASMA PROTEIN BINDING; DIURNAL VARIATION;
D O I
10.1111/j.1365-2125.1994.tb04338.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of multiple doses of vinpocetine (10 mg three times daily) on the steady state plasma concentrations of oxazepam (10 mg three times daily) was studied in 16 healthy subjects. The mean (+/- s.d.) AUC (ng ml(-1) h(-1)) of oxazepam over 24 h during combined treatment was 4716 +/- 2296 and for oxazepam treatment alone it was 4737 +/- 2448 (95% confidence intervals for ratio of means = 95.4-103.7%). The degree of plasma protein binding of oxazepam was 98.11 +/- 0.32% and was not affected by vinpocetine. Independent of vinpocetine treatment a significant diurnal change in the plasma binding of oxazepam was observed; the free drug fraction was 20% higher during the night than during the day. C-max and AUC values based on total oxazepam in plasma were 10% lower during the night. The results indicate a lack of influence of vinpocetine on oxazepam kinetics. Diurnal changes in the plasma binding of oxazepam probably have no clinical consequences.
引用
收藏
页码:143 / 146
页数:4
相关论文
共 50 条
  • [1] LACK OF PHARMACOKINETIC INTERACTION BETWEEN CIMETIDINE AND PIRENZEPINE
    JAMALI, F
    MAHACHAI, V
    REILLY, PA
    THOMSON, ABR
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1985, 8 (03): : A99 - A99
  • [2] Lack of pharmacokinetic interaction between roflumilast and midazolam
    Nassr, N
    Lahu, G
    Wolf, D
    Erb, K
    Knoerzer, D
    Zech, K
    Wurst, W
    Hermann, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 715 - 715
  • [3] Lack of pharmacokinetic interaction between mexiletine and omeprazole
    Kusumoto, M
    Ueno, K
    Tanaka, K
    Takeda, K
    Mashimo, K
    Kameda, T
    Fujimura, Y
    Shibakawa, M
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (02) : 182 - 184
  • [4] Lack of a pharmacokinetic interaction between moexipril and hydrochlorothiazide
    Hutt, V
    Michaelis, K
    Verbesselt, R
    DeSchepper, PJ
    Salomon, P
    Bonn, R
    Cawello, W
    Angehrn, JC
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (3-4) : 339 - 344
  • [5] LACK OF PHARMACOKINETIC INTERACTION BETWEEN CHLOROQUINE AND IMIPRAMINE
    ONYEJI, CO
    TORIOLA, TA
    OGUNBONA, FA
    THERAPEUTIC DRUG MONITORING, 1993, 15 (01) : 43 - 46
  • [6] Lack of a pharmacokinetic interaction between atovaquone and proguanil
    Gillotin, C
    Mamet, JP
    Veronese, L
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (04) : 311 - 315
  • [7] Lack of pharmacokinetic interaction between anidulafungin and tacrolimus
    Dowell, James A.
    Stogniew, Martin
    Krause, David
    Henkel, Timothv
    Damle, Bharat
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (03): : 305 - 314
  • [8] Lack of pharmacokinetic interaction between sumatriptan and naproxen
    Srinivasu, P
    Rambhau, D
    Rao, BR
    Rao, YM
    JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (01): : 99 - 104
  • [9] A LACK OF PHARMACOKINETIC INTERACTION BETWEEN RANITIDINE AND PIROXICAM
    DIXON, JS
    LACEY, LF
    PICKUP, ME
    LANGLEY, SJ
    PAGE, MC
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (06) : 583 - 586
  • [10] Lack of a pharmacokinetic interaction between atovaquone and proguanil
    C. Gillotin
    J. P. Mamet
    L. Veronese
    European Journal of Clinical Pharmacology, 1999, 55 : 311 - 315